Comments on the publication of Khakimov G. A. et al. “Successful surgical treatment of chemoresistant mediastinal germ cell tumor”

1. Каприн А. Д., Старинский В. В., Шахзадова А. О. Злокачественные новообразования в России в 2020 году (заболеваемость и смертность) / А. Д. Каприн, В. В. Старинский, А. О. Шахзадова, Москва : МНИОИ им. П. А. Герцена − филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2021. 252 c.

2. Feldman D. R. State-of-the-Art Management of Germ Cell Tumors // American Society of Clinical Oncology Educational Book. 2018. № 38. C. 319–323.

3. Fizazi K. [и др.]. Viable Malignant Cells After Primary Chemotherapy for Disseminated Nonseminomatous Germ Cell Tumors : Prognostic Factors and Role of Postsurgery Chemotherapy—Results From an International Study Group // Journal of Clinical Oncology. 2001. № 10 (19). C. 2647–2657.

4. Fizazi K. [и др.]. Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT) : results of the sCR2 international study // Annals of Oncology. 2008. № 2 (19). C. 259–264.

5. Hsieh M. [и др.]. A case series and literature review on 98 pediatric patients of germ cell tumor developing growing teratoma syndrome // Cancer Medicine. 2023. № 12 (12). C. 13256–13269.

6. Logothetis C. J. [и др.]. The growing teratoma syndrome // Cancer. 1982. № 8 (50). C. 1629–1635.

7. Smithers D. W. MATURATION IN HUMAN TUMOURS // The Lancet. 1969. № 7627 (294). C. 949–952.